The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism
The Journal of Clinical Endocrinology & Metabolism · 16.09.2024 · 109 (10) · 2681-2691
DOI: 10.1210/clinem/dgae415 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.06.2024. Verfasst von Jia-Yuh Sheu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Taiwan University Hospital, Taipei 100225, Taiwan. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypertension, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Context
Investigating the co-occurrence of obstructive sleep apnea (OSA) and primary aldosteronism (PA) is crucial for understanding their interrelation.
Objective
This work aimed to evaluate the prevalence of OSA in individuals diagnosed with PA and to assess the prevalence of PA within the OSA population, with a specific focus on hypertensive individuals.
Methods
An exhaustive search was performed across PubMed, Embase, CINAHL, Scopus, and Web of Science up to September 2023, without restrictions on language or publication date. Studies were selected based on their focus on the prevalence of OSA in PA patients and vice versa, specifically in hypertensive individuals. Data were extracted using standard guidelines, focusing on patient characteristics, prevalence rates, and other relevant clinical parameters.
Results
Proportional meta-analysis using a random-effects model revealed a 59.8% prevalence of OSA in hypertensive PA patients, with 45.4% exhibiting moderate-to-severe OSA. Meta-regression showed no significant effect of age, sex, body mass index, antihypertensive medication, systolic blood pressure, diastolic blood pressure, or serum potassium on OSA prevalence. However, a significant positive association was found with the glomerular filtration rate (GFR) (P < .001). Subgroup analysis also revealed that a hyperfiltration rate (GFR ≥ 100 mL/min per 1.73 m2) may be associated with a higher prevalence of OSA (71%, P value for interaction < .01). Among hypertensive OSA patients, 11.2% had PA.
Conclusion
A substantial prevalence of OSA in individuals with PA was identified, demonstrating a complex interplay between these conditions in hypertensive patients. Notably, the prevalence of OSA was significantly associated with kidney hyperfiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, National Taiwan University Hospital, Taipei 100225, Taiwan.
- College of Medicine, National Taiwan University, Taipei 106319, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan 71004, Taiwan.
- Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan 71710, Taiwan.
- Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100225, Taiwan.
- Primary Aldosteronism Center of National Taiwan University Hospital, Taipei 100225, Taiwan.
ORCID-Profile: Jia-Yuh Sheu, Jui-Yi Chen, Vin-Cent Wu, Jeff S Chueh
Zitieren
APA
Sheu, J. Y., Chang, L. Y., Chen, J. Y., Chuang, M. H., Wu, V. C., & Chueh, J. S. (2024). The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism, 109(10), 2681-2691. https://doi.org/10.1210/clinem/dgae415
Vancouver
Sheu JY, Chang LY, Chen JY, Chuang MH, Wu VC, Chueh JS. The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 2024;109(10):2681-2691. doi:10.1210/clinem/dgae415
BibTeX
@article{Sheu2024,
author = {Sheu, Jia-Yuh and Chang, Li-Yang and Chen, Jui-Yi and Chuang, Min-Hsiang and Wu, Vin-Cent and Chueh, Jeff S},
title = {The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {10},
pages = {2681--2691},
doi = {10.1210/clinem/dgae415}
}
EUVIMED